(Q37760083)

22 August 2017

22 May 2010

1 reference

Supportive Care in Cancer

22 August 2017

1 reference

22 August 2017

18

1 reference

22 August 2017

8

1 reference

22 August 2017

1081-1087

1 reference

https://scigraph.springernature.com/pub.10.1007/s00520-010-0902-1

22 August 2017

0 references

cites work

Dosimetric predictors of xerostomia for head-and-neck cancer patients treated with the smart (simultaneous modulated accelerated radiation therapy) boost technique

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00520-010-0902-1

Relation between acute and late irradiation impairment of four basic tastes and irradiated tongue volume in patients with head-and-neck cancer.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00520-010-0902-1

Oral gossypol in the treatment of patients with refractory metastatic breast cancer: a phase I/II clinical trial.

21 January 2018

1 reference

12 December 2020

Neoadjuvant docetaxel before radical prostatectomy in patients with high-risk localized prostate cancer

1 reference

12 December 2020

Acute radiation toxicity assessment of a 3-D conformal head and neck radiation treatment technique

1 reference

12 December 2020

Impact of nutrition on outcome: A prospective randomized controlled trial in patients with head and neck cancer undergoing radiotherapy

1 reference

12 December 2020

Toxicity and health-related quality of life in breast cancer patients receiving adjuvant docetaxel, doxorubicin, cyclophosphamide (TAC) or 5-fluorouracil, doxorubicin and cyclophosphamide (FAC): impact of adding primary prophylactic granulocyte-colo

1 reference

12 December 2020

Is weekly docetaxel an active and gentle chemotherapy in the treatment of metastatic breast cancer?

1 reference

12 December 2020

Neovastat (AE-941) in refractory renal cell carcinoma patients: report of a phase II trial with two dose levels

1 reference

12 December 2020

Zinc gluconate in the treatment of dysgeusia--a randomized clinical trial

1 reference

12 December 2020

Effects of amifostine on acute toxicity from concurrent chemotherapy and radiotherapy for inoperable non-small-cell lung cancer: report of a randomized comparative trial

1 reference

12 December 2020

Taste and smell alterations in cancer patients--real problems with few solutions.

1 reference

12 December 2020

Changes in quality of life of head-and-neck cancer patients following postoperative radiotherapy

1 reference

12 December 2020

High-dose sequential chemotherapy with recombinant granulocyte colony-stimulating factor and repeated stem-cell support for inflammatory breast cancer patients: does impact on quality of life jeopardize feasibility and acceptability of treatment?

1 reference

12 December 2020

Qualitative and quantitative assessment of taste and smell changes in patients undergoing chemotherapy for breast cancer or gynecologic malignancies

1 reference

12 December 2020

Oral status during radiotherapy and chemotherapy: a descriptive study of patient experiences and the occurrence of oral complications.

1 reference

12 December 2020

Intensity-modulated radiation therapy for the treatment of nonanaplastic thyroid cancer

1 reference

12 December 2020

Does zinc sulfate prevent therapy-induced taste alterations in head and neck cancer patients? Results of phase III double-blind, placebo-controlled trial from the North Central Cancer Treatment Group (N01C4)

1 reference

12 December 2020

The effect of education in managing side effects in women receiving chemotherapy for treatment of breast cancer

1 reference

12 December 2020

IMRT with the use of simultaneous integrated boost in treatment of head and neck cancer: acute toxicity evaluation

1 reference

12 December 2020

Late toxicity results of the GORTEC 94-01 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced-stage oropharynx carcinoma: comparison of LENT/SOMA, RTOG/EORTC, and NCI-CTC scoring systems

1 reference

12 December 2020

Induction paclitaxel, carboplatin, and infusional 5-FU followed by concurrent radiation therapy and weekly paclitaxel/carboplatin in the treatment of locally advanced head and neck cancer: a phase II trial of the Minnie Pearl Cancer Research Network

1 reference

12 December 2020

Symptom profile of nasopharyngeal cancer patients during radiation therapy

1 reference

12 December 2020

1 reference

12 December 2020

Confocal microscopy of the peripheral gustatory system: comparison between healthy subjects and patients suffering from taste disorders during radiochemotherapy

1 reference

12 December 2020

Changing quality of life in patients with advanced head and neck cancer after primary radiotherapy or chemoradiation.

1 reference

12 December 2020

Radiochemotherapy with amifostine cytoprotection for head and neck cancer

1 reference

12 December 2020

Taste and odor abnormalities in cancer patients.

1 reference

12 December 2020

Quality of life and oral function in patients treated with radiation therapy for head and neck cancer.

1 reference

12 December 2020

Chemosensory alterations and cancer therapies.

1 reference

12 December 2020

A Phase I clinical and pharmacological study of cis-diamminedichloro(2-methylpyridine) platinum II (AMD473).

1 reference

12 December 2020

Prospective phase II trial of concomitant boost radiotherapy for stage II nasopharyngeal carcinoma: an evaluation of response and toxicity.

1 reference

12 December 2020

Quality of life following resection, free flap reconstruction and postoperative external beam radiotherapy for squamous cell carcinoma of the base of tongue.

1 reference

12 December 2020

Dysphagia in treated nasopharyngeal cancer

1 reference

12 December 2020

Systematic reviews of oral complications from cancer therapies, Oral Care Study Group, MASCC/ISOO: methodology and quality of the literature

1 reference

12 December 2020

Multifactorial analysis on the short-term side effects occurring within 96 hours after radioiodine-131 therapy for differentiated thyroid carcinoma

1 reference

12 December 2020

10.1007/S00520-010-0902-1

Identifiers

DOI

1 reference

22 August 2017

1 reference

PubMed ID

20495984